{"id":"W2892343964","doi":"10.1007/s10549-018-4967-8","title":"Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials","year":2018,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Hazard ratio; Oncology; Meta-analysis; Odds ratio; Randomized controlled trial; Population; Adjuvant; Confidence interval; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01016907,0.002630433,0.01602015,0.001675524,0.0003624047,0.00233843,0.001968056,0.00203662,0.003901157],"category_scores_gemma":[0.01902639,0.001280187,0.02733352,0.002286034,0.0006340572,0.001951603,0.001085469,0.00293861,0.0002437138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001868286,"about_ca_system_score_gemma":0.001719538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003314657,"about_ca_topic_score_gemma":0.007255404,"domain_scores_codex":[0.9937693,0.003562497,0.00127213,0.0007439879,0.0003972306,0.0002548315],"domain_scores_gemma":[0.9894856,0.008458087,0.001227614,0.0003120762,0.0003147677,0.0002018404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.03297644,0.0000844271,0.003633433,0.1580267,0.7786748,0.0001066631,0.00007468614,0.001215385,0.0004202077,0.0002412264,0.0006137688,0.02393227],"study_design_scores_gemma":[0.007227263,0.0006991723,0.002608986,0.005769156,0.9816054,0.00005391792,0.00003729343,0.000263757,0.0001094579,0.0004275291,0.001174303,0.00002383013],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01070625,0.9875492,0.0007602031,0.0001602117,0.0002028264,0.0001465461,0.0002100638,0.00002293779,0.0002417826],"genre_scores_gemma":[0.379832,0.6128938,0.003377829,0.001471193,0.0004488417,0.0005112845,0.000800758,0.00005228486,0.0006120645],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9839798,"threshold_uncertainty_score":0.05377984,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3371883552928294,"score_gpt":0.5253974729976785,"score_spread":0.188209117704849,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}